| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Ibrutinib | Ibrutinib (S)-Isomer | VE007027 | View CAS 936563-97-2 |
| Ibrutinib | Ibrutinib Dimer 2 | VE0011242 | View CAS 2417548-83-3 |
| Ibrutinib | Ibrutinib Impurity A | VE0011243 | View |
| Ibrutinib | Ibrutinib Impurity C | VE0011244 | View CAS 2417548-76-4 |
| Ibrutinib | Ibrutinib Impurity D | VE0011245 | View CAS 2031255-26-0 |
| Ibrutinib | Ibrutinib impurity G | VE0010121 | View CAS 2031255-23-7 |
| Catalogue No. | VE0010121 |
| CAS No. | 2031255-23-7 |
| Molecular Formula | C50H48N12O4 |
| Molecular Weight | 880.99 g/mol |
| Parent drug | Ibrutinib |
| IUPAC Name | 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyrimidin-1-yl]-1-piperidyl]-3-[[(1R)-3-(4-phenoxyphenyl)-1-(1-prop-2-enoyl-3-piperidyl)pyrazolo[3, 4-d]pyrimidin-4-yl]amino]propan-1-one |
| Synonyms | N/A |
| References | – |
| Status | In-stock |
| ListName | Ibrutinib impurity G |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
